We are live on ! Find out more
RGC

Roberts, Glore & Co Portfolio holdings

AUM $364M
1-Year Est. Return 19.54%
This Fund
S&P 500
This Quarter Est. Return
+11.01%
1 Year Est. Return
+19.54%
3 Year Est. Return
+59.43%
5 Year Est. Return
+77.93%
10 Year Est. Return
+273.65%
AUM
$380M
AUM Growth
+$51.2M
Cap. Flow
+$18.7M
Cap. Flow %
4.92%
Top 10 Hldgs %
38.28%
Holding
210
New
18
Increased
73
Reduced
84
Closed
3

Top Buys

Rank Stock Value
1
ABBV icon
AbbVie
ABBV
+$7.91M
2
ABT icon
Abbott
ABT
+$7.76M
3
BND icon
Vanguard Total Bond Market
BND
+$1.35M
4
OGN icon
Organon & Co
OGN
+$938K
5
V icon
Visa
V
+$610K

Sector Composition

Rank Sector Weight
1 Healthcare 25.08%
2 Technology 16.71%
3 Financials 10.29%
4 Industrials 9.17%
5 Communication Services 6.39%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ABT icon
1
Abbott
ABT
$181B
$22.1M 5.81%
156,972
+60,649
+63% +$7.76M
BRK.B icon
2
Berkshire Hathaway Class B
BRK.B
$1.1T
$20.7M 5.45%
69,341
+513
+0.7% +$147K
MSFT icon
3
Microsoft
MSFT
$3.42T
$19.1M 5.02%
56,712
-323
-0.6% -$105K
ABBV icon
4
AbbVie
ABBV
$444B
$18.9M 4.97%
139,481
+66,929
+92% +$7.91M
AAPL icon
5
Apple
AAPL
$4.44T
$18.5M 4.86%
103,980
-1,234
-1% -$195K
JNJ icon
6
Johnson & Johnson
JNJ
$611B
$11.7M 3.08%
68,519
+474
+0.7% +$77.6K
GOOG icon
7
Alphabet (Google) Class C
GOOG
$4.22T
$10.3M 2.72%
71,400
-300
-0.4% -$43.4K
VTI icon
8
Vanguard Morningstar Total Stock Market ETF
VTI
$656B
$10.1M 2.67%
41,979
+730
+2% +$172K
GOOGL icon
9
Alphabet (Google) Class A
GOOGL
$4.22T
$7.64M 2.01%
52,760
-1,040
-2% -$150K
PEP icon
10
PepsiCo
PEP
$190B
$6.51M 1.71%
37,465
-495
-1% -$80.9K
VPL icon
11
Vanguard FTSE Pacific ETF
VPL
$8.06B
$6.3M 1.66%
80,731
-7,500
-9% -$599K
SYK icon
12
Stryker
SYK
$123B
$5.73M 1.51%
21,439
-68
-0.3% -$17.8K
WIW
13
Western Asset Inflation-Linked Opportunities & Income Fund
WIW
$508M
$5.62M 1.48%
413,619
+1,438
+0.3% +$19.4K
CSCO icon
14
Cisco
CSCO
$452B
$5.55M 1.46%
87,567
-174
-0.2% -$9.94K
ITW icon
15
Illinois Tool Works
ITW
$81.4B
$5.15M 1.35%
20,877
-192
-0.9% -$44.6K
SPY icon
16
State Street SPDR S&P 500 ETF Trust
SPY
$784B
$4.55M 1.2%
9,572
-1,448
-13% -$665K
EXPD icon
17
Expeditors International
EXPD
$22B
$4.4M 1.16%
32,758
-295
-0.9% -$36.9K
AMZN icon
18
Amazon
AMZN
$2.91T
$4.37M 1.15%
26,180
ATRI
19
DELISTED
Atrion Corp
ATRI
$4.22M 1.11%
5,991
+84
+1% +$60.4K
INTC icon
20
Intel
INTC
$471B
$4.21M 1.11%
81,689
+649
+0.8% +$33.2K
BAB icon
21
Invesco Taxable Municipal Bond ETF
BAB
$1.02B
$4.17M 1.1%
126,610
-223
-0.2% -$7.36K
BRK.A icon
22
Berkshire Hathaway Class A
BRK.A
$1.1T
$4.06M 1.07%
9
TECH icon
23
Bio-Techne
TECH
$11.2B
$3.73M 0.98%
28,868
-276
-0.9% -$33.8K
NSC icon
24
Norfolk Southern
NSC
$74.7B
$3.71M 0.98%
12,476
-156
-1% -$43.6K
WIA
25
Western Asset Inflation-Linked Income Fund
WIA
$185M
$3.69M 0.97%
278,705
+3,921
+1% +$54.6K

Similar funds

Roberts, Glore & Co's Q4 2021 Portfolio in Review

As of Q4 2021, Roberts, Glore & Co held 210 positions worth $380M, up 16% from $329M the previous quarter. Its ten largest holdings account for 38% of the portfolio.

Roberts, Glore & Co deployed $18.7M of net new capital in Q4 2021, opening 18 new positions and adding to 73 existing holdings. Its largest new stake was Organon & Co: 28,791 shares worth $877K.

By sector, the portfolio is most concentrated in Healthcare at 25% of assets, up from 21% a quarter earlier, followed by Technology and Financials.

On the sell side, the largest reduction was Cerner Corp, an estimated $1.16M trimmed.

  • Roberts, Glore & Co's largest Q4 2021 buy was Organon & Co: 28,791 shares worth $877K.
  • Roberts, Glore & Co added most to AbbVie in Q4 2021, an estimated $7.91M increase.
  • Roberts, Glore & Co's biggest Q4 2021 reduction was Cerner Corp, cutting an estimated $1.16M.
  • Roberts, Glore & Co fully exited Dell in Q4 2021, selling an estimated $298K.
  • Roberts, Glore & Co's ten largest holdings make up 38% of its $380M portfolio in Q4 2021.
  • Roberts, Glore & Co opened 18 new positions and closed 3 in Q4 2021.
  • Roberts, Glore & Co's portfolio value rose 16% quarter-over-quarter to $380M.

Based on Roberts, Glore & Co's 13F filing for Q4 2021, filed 11 Feb 2022.